These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23715566)

  • 1. Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
    Clement J; Varlotto J; Rybka W; Frauenhoffer E; Drabick JJ
    J Clin Oncol; 2013 Jul; 31(19):e316-9. PubMed ID: 23715566
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
    Foa C; Magné N; Bondiau PY; Otto J; Thyss A
    Bone Marrow Transplant; 2000 Nov; 26(9):1029. PubMed ID: 11100286
    [No Abstract]   [Full Text] [Related]  

  • 3. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
    Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
    Leo E; Schlegel PG; Lindemann A
    J Neurooncol; 1997 Apr; 32(2):149-54. PubMed ID: 9120544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
    Burke MJ; Walterhouse DO; Jacobsohn DA; Duerst RE; Kletzel M
    Pediatr Blood Cancer; 2007 Aug; 49(2):196-8. PubMed ID: 17417796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
    Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
    Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
    J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
    Anderton J; Moroz V; Marec-Bérard P; Gaspar N; Laurence V; Martín-Broto J; Sastre A; Gelderblom H; Owens C; Kaiser S; Fernández-Pinto M; Fenwick N; Evans A; Strauss S; Whelan J; Wheatley K; Brennan B
    Trials; 2020 Jan; 21(1):96. PubMed ID: 31952545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
    Paulino AC; Nguyen TX; Mai WY; Teh BS; Wen BC
    Pediatr Blood Cancer; 2007 Aug; 49(2):145-8. PubMed ID: 16732580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
    Rutkowski S; Bode U; Deinlein F; Ottensmeier H; Warmuth-Metz M; Soerensen N; Graf N; Emser A; Pietsch T; Wolff JE; Kortmann RD; Kuehl J
    N Engl J Med; 2005 Mar; 352(10):978-86. PubMed ID: 15758008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
    J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
    Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of extraneural metastasis of medulloblastoma successfully treated with cisplatin and etoposide].
    Kanai H; Nagai H; Mabe H; Wakabayashi S; Yamashita N
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):545-7. PubMed ID: 1558405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
    Kuperman AA; Kornreich L; Feinmesser M; Ash S; Yaniv I; Cohen IJ
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):e25-6. PubMed ID: 22935658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
    Zia MI; Forsyth P; Chaudhry A; Russell J; Stewart DA
    Bone Marrow Transplant; 2002 Nov; 30(9):565-9. PubMed ID: 12407430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.